Literature DB >> 8871000

Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: a prospective study of treatment practice at the Royal Marsden Hospital.

I N Fernando1, H T Ford, T J Powles, S Ashley, J P Glees, M Torr, D Grafton, C L Harmer.   

Abstract

The results are presented of a prospective study of acute skin toxicity in 197 patients with early stage breast cancer, who were treated by conservative surgery and postoperative radiotherapy. We have examined the factors determining the severity of the acute skin reaction with particular reference to the degree of dry or moist desquamation at the completion of treatment. One hundred and ten patients had treatment with radiotherapy alone. The remaining 87 received synchronous chemotherapy with breast irradiation, using either the 3M or the 2M regimen, consisting of mitoxantrone and methotrexate, with (3M) or without Mitomycin-C (2M). Patients were analysed according to both the severity and the site of the skin reaction, age, dose, dose variation across the central outline, treatment technique, beam energy, field separation and breast size. A univariate analysis of these results, which has been presented as an odds ratio of the likelihood of developing a moderate or severe reaction in comparison with those scored as mild, has shown that several factors are associated with an increase in the acute skin reaction. These include the use of the semi-supine technique (odds ratio (OR) = 7.3 (95% CI 3.7-14.6)), beam energy (60Co: 6-10 MV photons OR = 5.9 (95% CI 2.6-13.4)), field separation (> or = 20 cm: < 20 cm OR = 4.1 (95% CI 2.2-7.8)), dose variation across the central outline (> or = 10%: < 10% OR = 9.7 (95% CI 2.6-36.4)), inclusion of the axilla (OR = 4.6 (95% CI 2.4-8.9)), and bust size (bra cup size C and D: A and B OR = 4.6 (95% CI 2.7-11.9)). Using multivariate logistic regression, the technique of radiation delivery and bust size were shown to be independently significant variables affecting acute skin reaction. In view of the high correlation between variables (e.g. radiotherapy technique and beam energy) it is still not possible to specify with definite certainty which is the primary variable causing the skin reaction. However 20/57 (35%) of patients treated by the semisupine technique sustained a severe skin reaction, with > 10% dry or moist desquamation in the treatment field. This compares with only 6/140 (4%) patients treated by the supine method. A possible mechanism by which treatment using the semisupine technique may enhance acute toxicity is discussed. We conclude that there are both treatment and patient related factors that will increase the acute skin reaction after breast irradiation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871000     DOI: 10.1016/s0936-6555(05)80657-0

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  27 in total

1.  Correlation between anthropometric parameters and acute skin toxicity in breast cancer radiotherapy patients: a pilot assessment study.

Authors:  Benoîte Méry; Alexis Vallard; Jane-Chloé Trone; Cécile Pacaut; Jean-Baptiste Guy; Sophie Espenel; Julien Langrand-Escure; Edouard Ollier; Guoping Wang; Peng Diao; Lise Bigot; Sylvie Mengue Ndong; Claire Bosacki; Majed Ben Mrad; Nicolas Magné
Journal:  Br J Radiol       Date:  2015-09-22       Impact factor: 3.039

2.  Do hypofraction and large breast size reciprocally fit in breast cancer radiotherapy?

Authors:  Pierfrancesco Franco; Sara Bartoncini; Stefania Martini; Giuseppe Carlo Iorio; Umberto Ricardi
Journal:  Ann Transl Med       Date:  2019-07

3.  Preemptive treatment with Xonrid®, a medical device to reduce radiation induced dermatitis in head and neck cancer patients receiving curative treatment: a pilot study.

Authors:  Nicola Alessandro Iacovelli; Simona Naimo; Francesca Bonfantini; Anna Cavallo; Paolo Bossi; Carlo Fallai; Emanuele Pignoli; Salvatore Alfieri; Cristiana Bergamini; Federica Favales; Ester Orlandi
Journal:  Support Care Cancer       Date:  2017-01-20       Impact factor: 3.603

4.  Elevated ARG1 expression in primary monocytes-derived macrophages as a predictor of radiation-induced acute skin toxicities in early breast cancer patients.

Authors:  Karen Jung; Siham Sabri; John Hanson; Yaoxian Xu; Ying Wayne Wang; Raymond Lai; Bassam S Abdulkarim
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

5.  Quality of life of women treated with radiotherapy for breast cancer.

Authors:  T S Lee; S L Kilbreath; K M Refshauge; S C Pendlebury; J M Beith; M J Lee
Journal:  Support Care Cancer       Date:  2007-09-18       Impact factor: 3.603

6.  Surgical outcomes of acellular human dermal grafts for large conjunctiva defects in orbital implant insertion.

Authors:  Su-Kyung Jung; Ji-Sun Paik; Uk-Hyun Sonn; Suk-Woo Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-05-19       Impact factor: 3.117

7.  Correlation Between Dosimetric Parameters and Acute Dermatitis of Post-operative Radiotherapy in Breast Cancer Patients.

Authors:  Tadashi Takenaka; Hideya Yamazaki; Gen Suzuki; Norihiro Aibe; Koji Masui; Daisuke Shimizu; Takeshi Nishimura; Akihiro Nakashima; Toshiyuki Ogata; Keiichiro Matsushita; Ken Yoshida; Kei Yamada
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

8.  Reduction and Mastopexy Techniques for Optimal Results in Oncoplastic Breast Reconstruction.

Authors:  Jessica F Rose; Jessica Suarez Colen; Warren A Ellsworth
Journal:  Semin Plast Surg       Date:  2015-05       Impact factor: 2.314

9.  Protective effects of doxepin cream on radiation dermatitis in breast cancer: A single arm double-blind randomized clinical trial.

Authors:  Laleh Shariati; Alireza Amouheidari; Hajar Naji Esfahani; Alireza Abed; Shaghayegh Haghjooy Javanmard; Ismail Laher; Ahmad Ghasemi; Golnaz Vaseghi
Journal:  Br J Clin Pharmacol       Date:  2020-02-25       Impact factor: 4.335

Review 10.  Multidisciplinary approach of early breast cancer: the biology applied to radiation oncology.

Authors:  Céline Bourgier; Mahmut Ozsahin; David Azria
Journal:  Radiat Oncol       Date:  2010-01-14       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.